This content is for informational purposes only and is not a substitute for professional advice.
Creatine is one of the rare supplements with strong evidence for training performance, yet it is still easy to test badly. The common mistake is checking for a dramatic day-one change. Creatine is not caffeine. The more realistic question is whether daily creatine improves repeat high-intensity work, training volume, recovery, or selected cognitive tasks after stores have had time to rise.
This protocol separates training and cognition so one blurry story does not swallow the whole result. It also keeps creatine inside a broader stack composition decision: one ingredient, one dose, one review date, and no new performance aids during the trial.
The hypothesis
The testable claim is that daily creatine monohydrate improves at least one preselected training metric, or one preselected cognitive metric, without unacceptable GI symptoms, water-weight concerns, or lab-interpretation issues.
The training case is stronger than the cognition case. The International Society of Sports Nutrition position stand describes creatine monohydrate as effective for increasing high-intensity exercise capacity and lean mass during training, with a large safety literature in healthy populations.1 Cognitive reviews are more cautious: creatine may help short-term memory or reasoning in some settings, with stronger signals in older adults, vegetarians, sleep-deprived states, or cognitively demanding conditions, and less consistent effects in young rested adults.2 3
Baseline window
Run a 14-day baseline. Keep training program, exercise selection, set structure, caffeine, sleep schedule, dietary protein, carbohydrate intake, and body-weight measurement routine stable. Do not start a new hypertrophy block, cut calories aggressively, add beta-alanine, add a pre-workout, or change caffeine during baseline.
If you are already using creatine, a true test requires a longer off period before baseline. Many people choose not to wash out fully because it can take weeks for stores to drift down. In that case, label the protocol as a dose-timing or adherence experiment, not a first-start creatine test.
| Baseline item | Rule |
|---|---|
| Duration | 14 days |
| Training | Same program and progression rules |
| Diet | Stable protein, calories, and carbohydrate pattern |
| Body weight | Same scale, same time, at least 4 mornings per week |
| Cognitive task | Same test, same time of day, 3-5 sessions per week |
Choose either a training-primary protocol or a cognition-primary protocol. You can track both, but only one should decide success.
Active window
Run a 42-day active window. Use creatine monohydrate unless you have a specific reason to test another form. A common conservative approach is 3-5 g daily without a loading phase. Loading can saturate muscle faster, but it also increases GI and water-weight noise, which makes a home trial harder to read.
Take creatine at the same time each day, with food if that improves tolerance. Missing an occasional dose is not catastrophic, but adherence below 85% makes interpretation weaker.
| Active item | Rule |
|---|---|
| Duration | 42 days |
| Dose | 3-5 g creatine monohydrate daily |
| Timing | Same daily routine, any consistent time |
| Loading | Avoid loading unless the protocol specifically tests loading |
| Decision timing | Review after day 42 |
Metrics to track
For training, use metrics that match creatine's likely effect: repeated efforts, volume tolerance, and high-intensity output. For cognition, use a repeatable task rather than general mood.
| Metric | How to record it | Success threshold |
|---|---|---|
| Top-set performance | Load x reps at fixed RPE for 1-2 key lifts | Clear improvement beyond program expectation |
| Volume tolerance | Completed working sets at target load and RPE | At least 5-10% more volume in comparable sessions |
| Repeat sprint or interval work | Output across repeated efforts | Less drop-off across later efforts |
| Recovery soreness | 1-10 next-day soreness after comparable sessions | Lower average without reduced training load |
| Body weight | Morning weight weekly average | Expected small increase flagged, not treated as fat gain |
| Cognitive task | Same 5-10 minute task at same time of day | Improvement beyond baseline practice trend |
Use a training log as the primary objective source. A subjective "felt stronger" note is useful context, but it should not decide the trial.
Confounders
Creatine sits inside training, diet, and water balance. Any of those can mimic or hide the effect.
| Confounder | Why it can distort the result | Control |
|---|---|---|
| New training block | Program novelty can drive rapid gains | Keep the same block or note the transition |
| Calorie surplus | More food improves training and weight gain | Keep calories stable |
| Carbohydrate change | Changes glycogen, water, and performance | Keep carb pattern stable |
| Caffeine or pre-workout | Acute ergogenic effect can dwarf creatine | Keep dose stable |
| Sleep debt | Reduces performance and cognitive scores | Flag poor sleep nights |
| Practice effect | Repeated cognitive tasks improve from learning | Use baseline practice sessions |
| Scale noise | Water shifts can look like body composition change | Use weekly weight averages |
Creatine can raise blood creatinine without kidney damage in many contexts, which can confuse lab interpretation. If you have kidney disease, reduced kidney function, abnormal labs, or a clinician tracking creatinine closely, discuss creatine before starting.
Washout and pause logic
Creatine washout is slower than stimulant washout. Use a 28-day pause if you need attribution confirmation, knowing that muscle creatine stores do not reset overnight. Keep training and diet stable during the pause, and keep logging the same metrics.
Pause rather than push through if GI symptoms appear, weight gain is psychologically or sport-category problematic, or upcoming lab work makes interpretation awkward. Restart only when the practical issue is resolved.
Stop criteria
Stop and get medical advice for persistent vomiting, severe diarrhea, signs of allergic reaction, unusual swelling, chest pain, faintness, dark urine after hard training, or any kidney-related warning from a clinician. Stop the trial if GI symptoms repeatedly interfere with eating or training.
Do not use this protocol to work around kidney disease, eating-disorder risk, aggressive weight-class cutting, or unexplained abnormal renal labs. Those situations need clinician guidance.
Expected time to signal
For training, expect the signal over 2-6 weeks. A loading phase can raise stores faster, but this protocol favors cleaner interpretation over speed. The clearest home signal is often not a one-rep max jump. It is more completed work at a similar effort, better repeat sets, or less drop-off late in sessions.
For cognition, expect a weaker and less certain signal. If you are young, omnivorous, well-rested, and already sleeping well, a null cognitive result is not surprising. If the cognitive endpoint is the main reason for testing, preselect one task and avoid claiming broad mental benefits from a tiny improvement.
How Unfair stores and reviews the plan
In Unfair, store creatine as a daily chronic protocol with dose, form, product, timing, training-primary or cognition-primary status, and the active-window end date. Training metrics should attach to workout logs, and cognitive metrics should attach to fixed test sessions, not general journal notes.
At review, Unfair compares baseline averages with weeks 5-6 of the active window. The first two active weeks can be shown but should not drive the decision. The final status should be keep, keep for training only, retest cognition with a better task, pause for labs or weight-class reasons, or remove.
References
This article is for education only and does not substitute for professional medical advice.
Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/
↩Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Exp Gerontol. 2018;108:166-173. https://pubmed.ncbi.nlm.nih.gov/29704637/
↩Prokopidis K, Giannos P, Triantafyllidis KK, et al. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023;81(4):416-427. https://pubmed.ncbi.nlm.nih.gov/35984306/
↩Vohra S, Shamseer L, Sampson M, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ. 2015;350:h1738. https://www.bmj.com/content/350/bmj.h1738
↩